Stockreport

Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment [Yahoo! Finance]

Pluri Inc.  (PLUR) 
PDF MAIT cells offer unique advantages compared to conventional T cells MAIT cells hold immense potential for immunotherapy, but their expansion has been a challenge thus [Read more]